SAN CLEMENTE, Calif., April 12, 2018 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of its first quarter 2018 earnings release and conference call.
The Company will release its first quarter 2018 results on Wednesday, May 9th, 2018 at approximately 4:00 p.m. EST (1:00 p.m. PST) and will be conducting a conference call concerning those results at 4:30 p.m. EST (1:30 p.m. PST) on Wednesday, May 9th, 2018. The call can be accessed at (800) 936-9761, conference ID 3029969. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical, Inc.
ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical devices used in vascular therapy, and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at www.icumed.com.
CONTACT:
ICU Medical, Inc.
Scott Lamb, Chief Financial Officer
(949) 366-4227
ICR, Inc.
John Mills, Partner
(646) 277-1254


Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 



